Is Biogen Inc (BIIB) Modestly Overvalued? A Comprehensive Valuation Analysis
Exploring the intrinsic value and financial health of Biogen Inc (BIIB)
Source: yahoo.com
Stay updated with breaking news from Iogen Stock. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Exploring the intrinsic value and financial health of Biogen Inc (BIIB)
The Dow Jones Industrial Average fell 211.16 points, or 0.63%, to 33,536.7, the S&P 500 lost 35.68 points, or 0.89%, to 3,957.25 and the Nasdaq Composite dropped 127.11 points, or 1.12%, to 11,196.22.
Biogen shares soared as much as 64% to a record high on the news that the Cambridge, Massachusetts-based biotechnology company receives approval from the U.S. Food and Drug Administration for Alzheimer’s treatment ADUHELM (Aducanumab).